Evidence map›Paper›PMID 33020304›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Mechanoactivation of NOX2-generated ROS elicits persistent TRPM8 Ca

Stephen J P Pratt, Rachel M Lee, Katarina T Chang, Erick O Hernández-Ochoa, David A Annis, Eleanor C Ory, Keyata N Thompson, Patrick C Bailey, Trevor J Mathias, Julia A Ju and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Microtubule-Dependent CaJournal of the American Heart Association · 2025
    Article
  3. Review
  4. Review
  5. Highly spatial-temporal electrochemical profiling of molecules trafficking at a single mitochondrion in one living cell.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Stephen J P PrattProgram in Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD 21201; sjppratt@umaryland.edu ssmartin@som.umaryland.edu.ORCID 0000-0003-3627-7258
Rachel M LeeDepartment of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD 21201.ORCID 0000-0001-9359-0422
Katarina T ChangDepartment of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD 21201.
Erick O Hernández-OchoaDepartment of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD 21201.ORCID 0000-0003-1138-1382
David A AnnisDepartment of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD 21201.
Eleanor C OryDepartment of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD 21201.
Keyata N ThompsonDepartment of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD 21201.
Patrick C BaileyProgram in Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD 21201.
Trevor J MathiasDepartment of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD 21201.
Julia A JuDepartment of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD 21201.
Michele I VitoloDepartment of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD 21201.
Martin F SchneiderDepartment of Biochemistry and Molecular Biology, School of Medicine, University of Maryland, Baltimore, MD 21201.
Joseph P StainsDepartment of Orthopaedics, School of Medicine, University of Maryland, Baltimore, MD 21201.ORCID 0000-0002-1610-4694
Christopher W WardDepartment of Orthopaedics, School of Medicine, University of Maryland, Baltimore, MD 21201.ORCID 0000-0001-6774-3579
Stuart S MartinDepartment of Pharmacology, School of Medicine, University of Maryland, Baltimore, MD 21201; sjppratt@umaryland.edu ssmartin@som.umaryland.edu.
University of Maryland, Baltimore · US

Funding

UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTERSUPPORT GRANTP30CA134274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Vu H. Duong · 2008 to 2026
$51.0M
Training Grant in Cancer BiologyT32CA154274 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI Toni M Antalis, CURT I CIVIN · 2011 to 2026
$6.8M
Tubulin microtentacles in detached mammary epithelial cellsR01CA124704 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI MARTIN, STUART S · 2007 to 2025
$5.7M
TRAINING PROGRAM IN INTEGRATIVE MEMBRANE BIOLOGYT32GM008181 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE · PI RIZZO, MEGAN A, TRUDEAU, MATTHEW C · 1987 to 2022
$4.9M
Roles of voltage sensor, S100A1 and calmodulin in skeletal muscle Ca2+ signalingR37AR055099 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI SCHNEIDER, MARTIN F · 2012 to 2021
$3.5M
Targeting microtubule stabilization to reduce breast tumor metastasisR01CA154624 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI MARTIN, STUART S · 2012 to 2023
$3.4M
PTEN loss increases efficiency of breast tumor metastasisK01CA166576 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI VITOLO, MICHELE I · 2013 to 2017
$524k
Mechanically-Activated Calcium Signaling in Breast Epithelial Cancer CellsF31CA232393 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI PRATT, STEPHEN J. P. · 2018 to 2020
$65k
Rapid analysis of patient tumor cell drug responses to reduce metastatic riskI01BX002746 · VA · BALTIMORE VA MEDICAL CENTER · PI MARTIN, STUART S · 2019 to 2024
–
BLRD VA I01 BX002746NCI NIH HHS F31 CA232393NCI NIH HHS K01 CA166576NCI NIH HHS P30 CA134274NCI NIH HHS R01 CA124704NCI NIH HHS R01 CA154624NCI NIH HHS T32 CA154274NIAMS NIH HHS R37 AR055099NIGMS NIH HHS T32 GM008181
6 · The paper itself

Abstract

Changes in the mechanical microenvironment and mechanical signals are observed during tumor progression, malignant transformation, and metastasis. In this context, understanding the molecular details of mechanotransduction signaling may provide unique therapeutic targets. Here, we report that normal breast epithelial cells are mechanically sensitive, responding to transient mechanical stimuli through a two-part calcium signaling mechanism. We observed an immediate, robust rise in intracellular calcium (within seconds) followed by a persistent extracellular calcium influx (up to 30 min). This persistent calcium was sustained via microtubule-dependent mechanoactivation of NADPH oxidase 2 (NOX2)-generated reactive oxygen species (ROS), which acted on transient receptor potential cation channel subfamily M member 8 (TRPM8) channels to prolong calcium signaling. In contrast, the introduction of a constitutively active oncogenic KRas mutation inhibited the magnitude of initial calcium signaling and severely blunted persistent calcium influx. The identification that oncogenic KRas suppresses mechanically-induced calcium at the level of ROS provides a mechanism for how KRas could alter cell responses to tumor microenvironment mechanics and may reveal chemotherapeutic targets for cancer. Moreover, we find that expression changes in both NOX2 and TRPM8 mRNA predict poor clinical outcome in estrogen receptor (ER)-negative breast cancer patients, a population with limited available treatment options. The clinical and mechanistic data demonstrating disruption of this mechanically-activated calcium pathway in breast cancer patients and by KRas activation reveal signaling alterations that could influence cancer cell responses to the tumor mechanical microenvironment and impact patient survival.

Indexed as

Mechanotransduction, CellularBreastBreast NeoplasmsCalciumCells, CulturedCell Transformation, NeoplasticEpithelial CellsFemaleHumansMicrotubulesNADPH Oxidase 2PrognosisProto-Oncogene Proteins p21(ras)Reactive Oxygen SpeciesSurvival RateTRPM Cation ChannelsCalciumCYBB protein, humanKRAS protein, humanNADPH Oxidase 2Proto-Oncogene Proteins p21(ras)Reactive Oxygen SpeciesTRPM8 protein, humanTRPM Cation Channelsbreast cancercalciummechanotransductionX-ROS; detyrosination

Identifiers

PMID33020304
PMCPMC7584994
OpenAlexW3091677464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.